Baheal Medical has actively practices ESG principles, promotes and improves ESG system construction and provides guidance direction for the enterprise’s sustainable development. The enterprise has compiled and disclosed its “2024 Environmental, Social and Governance (ESG) Report”, integrating ESG principles into all aspects of the enterprise’s production, operation and development goals.

Baheal Medical’s parent company, Baheal Pharma Group, has been consistently practicing sustainable development for many years. Under the strategic guidance of “Brand, Innovation and Internationalization”, Baheal Pharma Group has officially upgraded its Corporate Report from Corporate Social Responsibility Report to Corporate Sustainability Report in 2024. The iteration of this report is not only an update of reference standards and guidelines, but also a deep practice of sustainable development and a concrete implementation of Baheal’s highly forward-looking and pragmatic internationalization strategy. Through this report, Baheal Pharma Group systematically reviews its achievements in the areas of technological innovation, economy resilience, green and low-carbon development and social responsibility, addressing the profound expectations of stakeholders regarding the enterprise’s sustainable development.